DocSym
β
Searchsearch
Search
(C77.2) Secondary and unspecified malignant neoplasm: intra-abdominal lymph nodes
More details coming soon
796 389 in individuals diagnosis secondary and unspecified malignant neoplasm: intra-abdominal lymph nodes confirmed
38 714 deaths with diagnosis secondary and unspecified malignant neoplasm: intra-abdominal lymph nodes
5% mortality rate associated with the disease secondary and unspecified malignant neoplasm: intra-abdominal lymph nodes
Diagnosis secondary and unspecified malignant neoplasm: intra-abdominal lymph nodes is diagnosed Men are 16.88% more likely than Women
465 416
Men receive the diagnosis secondary and unspecified malignant neoplasm: intra-abdominal lymph nodes
27 736 (6.0 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
330 973
Women receive the diagnosis secondary and unspecified malignant neoplasm: intra-abdominal lymph nodes
10 978 (3.3 %)Died from this diagnosis.
Risk Group for the Disease secondary and unspecified malignant neoplasm: intra-abdominal lymph nodes - Men and Women aged 60-64
In Men diagnosis is most often set at age 0-94
Less common in men the disease occurs at Age 0-1, 95+Less common in women the disease occurs at Age 5-14
In Women diagnosis is most often set at age 0-5, 15-95+
Disease Features secondary and unspecified malignant neoplasm: intra-abdominal lymph nodes
Absence or low individual and public risk
Secondary and unspecified malignant neoplasm: intra-abdominal lymph nodes - what does this mean
Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes occurs when cancer cells from another part of the body (primary site) spread to the lymph nodes in the abdomen, causing them to become cancerous. this can be caused by a variety of factors, such as a weakened immune system, exposure to radiation, or certain types of infections.
What happens during the disease - secondary and unspecified malignant neoplasm: intra-abdominal lymph nodes
The pathogenesis of secondary and unspecified malignant neoplasms of the intra-abdominal lymph nodes is usually due to metastasis from a primary tumor elsewhere in the body. this occurs when cancer cells from the primary tumor travel through the bloodstream or lymphatic system and lodge in the lymph nodes, where they can grow and form a secondary tumor.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Physical Examination
- Blood Tests
- Imaging Tests (e.g. CT Scan, MRI, Ultrasound)
- Laparoscopy
- Biopsy
- Endoscopy
- Lymph Node Biopsy
Treatment and Medical Assistance
Main goal of the treatment: To reduce the size of the tumor and reduce the spread of the cancer.
- Chemotherapy
- Radiation therapy
- Surgery
- Immunotherapy
- Targeted drug therapy
- Hormone therapy
- Clinical trials
14 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Secondary and unspecified malignant neoplasm: intra-abdominal lymph nodes - Prevention
The best way to prevent secondary and unspecified malignant neoplasms of the intra-abdominal lymph nodes is to maintain a healthy lifestyle, including eating a balanced diet, exercising regularly, and avoiding smoking and excessive alcohol consumption. additionally, regular check-ups and screenings can help detect any potential signs of disease early on, allowing for early intervention and improved outcomes.